🇺🇸 FDA
Pipeline program

GWP42003-P

GWEP20238

Phase 3 small_molecule terminated

Quick answer

GWP42003-P for Seizures Associated With EMAS is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Seizures Associated With EMAS
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials